Dendritic Cell: all 48 studies that test it
Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Preventive Dendritic Cell Vaccination for Lynch SyndromeNot yet recruitingNCT07412197Phase 1/2
- A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid TumorRecruitingNCT06682117Not applicable
- Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid LeukemiaRecruitingNCT05000801Not applicable
- Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic SyndromeRecruitingNCT04999943Phase 1
- DC Vaccine in Colorectal CancerTerminatedNCT03730948Phase 1Results posted
- αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface MalignanciesCompletedNCT02151448Phase 1/2Results posted
- Dendritic Cell Vaccines + Dasatinib for Metastatic MelanomaCompletedNCT01876212Phase 2Results posted
- Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) PatientsTerminatedNCT00913913Phase 2Results posted
- A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic CarcinomaTerminatedNCT00843830Phase 1Results posted
- External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for SarcomaCompletedNCT00365872Phase 2Results posted
- Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung CancerCompletedNCT00103116Phase 2Results posted
- Dendritic Cell-immunotherapy for Advanced Hepatocellular CarcinomaActive, not recruitingNCT07726329Phase 2
- Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney DiseaseActive, not recruitingNCT06866158Phase 1/2
- Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade GliomasActive, not recruitingNCT06253234Phase 1
- Dendritic Cell Vaccination With Standard Postoperative Chemotherapy for the Treatment of Adult Ovarian CancerStatus unknownNCT05270720Phase 1
- Treatment of Recurrent Bladder Cancer With Dendritic CellsCompletedNCT04184232Phase 2
- MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung CancerStatus unknownNCT04082182Phase 1
- MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung CancerCompletedNCT04078269Phase 1
- Immunogenicity and Safety of DCs in Breast CancerCompletedNCT03450044Phase 1/2
- Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed GlioblastomaActive, not recruitingNCT03395587Phase 2
- Safety and Efficacy of Immune Therapy for CondylomaStatus unknownNCT03158480Not applicable
- Personalized DC Vaccine for Lung CancerStatus unknownNCT02956551Phase 1
- Safety and Efficacy of IDH1R132H-DC Vaccine in GliomasStatus unknownNCT02771301Not applicable
- Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT02638857Phase 1/2
- DC Vaccination in CMLTerminatedNCT02543749Phase 1/2
- Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young AdultsCompletedNCT02496520Phase 1/2
- Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma PatientsCompletedNCT02285413Phase 2
- Gene Expression Profiling of Malignant Tumor Predict the Therapeutic Response of DC-CIK ImmunotherapyCompletedNCT01906632Not applicable
- Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSIActive, not recruitingNCT01885702Phase 1/2
- Autologous Dendritic Cell Vaccine in Patients With Soft Tissue SarcomaStatus unknownNCT01883518Phase 1/2
- Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in RemissionActive, not recruitingNCT01686334Phase 2
- Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)CompletedNCT01671592Phase 1
- Study of DC Vaccination Against GlioblastomaStatus unknownNCT01567202Phase 2
- Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain TumorCompletedNCT01171469Phase 1
- Study of Chemo-Immunotherapy in Head and Neck Cancer PatientsStatus unknownNCT01149902Phase 1
- Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant MelanomaCompletedNCT00978913Phase 1
- Vaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic CellsCompletedNCT00948480Phase 2
- Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast CancerStatus unknownNCT00879489Phase 1/2
- Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-InfectionCompletedNCT00856154Phase 1
- Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic CancerStatus unknownNCT00795977Phase 1/2
- A Phase I Cancer Vaccine Study for Patients With Metastatic Breast CancerStatus unknownNCT00715832Phase 1
- Ovarian Dendritic Cell Vaccine TrialStatus unknownNCT00703105Phase 2
- Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid TumorsStatus unknownNCT00610389Phase 2
- Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain TumorsCompletedNCT00576537Phase 2
- Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma CellsStatus unknownNCT00327496Not applicable
- Vaccination of Patients With Stage IV Melanoma With Dendritic CellsCompletedNCT00125749Phase 1/2
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain CancerStatus unknownNCT00045968Phase 3
- Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.WithdrawnNCT00043212Phase 3